Patent US4727077A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4727077A Expired / Lapsed US ⏱️ 0.0 years remaining

Benzoyl urea compounds, process for their production, and antitumorous compositions containing them

Assignee: Ishihara Sangyo Kaisha Ltd
•
Filing: 1986-01-29
•
Granted: 1988-02-23
•
Expires: 2006-01-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A benzoyl urea compound having the formula: <IMAGE> (I) wherein A is a bromine atom or a chlorine atom.

Inventors

  • 👤 Takahiro Haga
  • 👤 Nobutoshi Yamada
  • 👤 Hideo Sugi
  • 👤 Toru Koyanagi
  • 👤 Nobuo Kondo
  • 👤 Tsunetaka Nakajima
  • 👤 Masahiro Watanabe
  • 👤 Kazumasa Yokoyama

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 11:23
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/02; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K31/495; A61K31/505; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K47/30; A61K47/36; A61K47/40; A61K47/44; A61K9/0012; A61K9/0019; A61K9/20; A61K9/2004; A61K9/2013; A61K9/48; A61K9/4841; A61K9/4858; C; C07; C07D; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/32; C07D239/34

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 18 words
A benzoyl urea compound having the formula: ##STR16## wherein A is a bromine atom or a chlorine atom.
Claim 2
Dependent Claim 18 words
A benzoyl urea compound having the formula: ##STR16## wherein A is a bromine atom or a chlorine atom.
Claim 3
Dependent Claim 11 words
The benzoyl urea compound according to claim 1, which is N-(2-nitrobenzoyl)-N'-[4-(5-bromo-2-pyrimidinyloxy)-3-chlorophenyl]urea.
Claim 4
Dependent Claim 11 words
The benzoyl urea compound according to claim 1, which is N-(2-nitrobenzoyl)-N'-[3-chloro-4-(5-chloro-2-pyrimidinyloxy)phenyl]urea.
Claim 5
Dependent Claim 32 words
An antitumorous composition comprising: an antitumorously effective amount of a benzoyl urea compound having the formula: ##STR17## where A is a bromine atom or a chlorine atom and a pharmaceutically acceptable adjuvant.
Claim 6
Dependent Claim 32 words
An antitumorous composition comprising: an antitumorously effective amount of a benzoyl urea compound having the formula: ##STR17## where A is a bromine atom or a chlorine atom and a pharmaceutically acceptable adjuvant.
Claim 7
Dependent Claim 15 words
The antitumorous composition according to claim 4, wherein the pharmaceutically acceptable adjuvant is a surfactant.
Claim 8
Dependent Claim 18 words
The antitumorous composition according to claim 4, wherein the pharmaceutically acceptable adjuvant is a phospholipid and an antioxidant.
Claim 9
Dependent Claim 26 words
The antitumorous composition according to claim 4, wherein at least 80% of the benzoyl urea compound has a particle size of not larger than 5 μm.
Claim 10
Dependent Claim 18 words
The antitumorous composition according to claim 4, which is applied for oral administration, intravenous administration or suppository administration.
Claim 11
Dependent Claim 13 words
The antitumorous composition according to claim 4, which is applied for oral administration.
Claim 12
Independent Claim 54 words
A method of treating a cancer resulting from the growth of P-388 leukemia cells, L-1210 leukemia cells, B-16 melanoma cells and M-5074 ovarium sarcoma cells, comprising: administering to a host subject suffering from said cancer an antitumorously effective amount of a benzoyl urea compound of the formula: ##STR18## wherein A is bromine or chlorine.
Claim 13
Independent Claim 54 words
A method of treating a cancer resulting from the growth of P-388 leukemia cells, L-1210 leukemia cells, B-16 melanoma cells and M-5074 ovarium sarcoma cells, comprising: administering to a host subject suffering from said cancer an antitumorously effective amount of a benzoyl urea compound of the formula: ##STR18## wherein A is bromine or chlorine.

References Cited (Backward Citations)

US435617A Cited
USB435617I5 Cited
SU795469A3 Cited
JPS57109721A Cited
EP0123861A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-02-22 1991-08-24 1992-02-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-02-22 1995-08-24 1996-02-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-02-22 1999-08-24 2000-02-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag